Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic Pulmonary Fibrosis (IPF) is a chronic lung disease marked by progressive scarring of lung tissue, making breathing difficult. Its cause remains unknown, and symptoms include shortness of breath, persistent dry cough, fatigue, and weight loss. IPF primarily affects individuals over 50, with risk factors like smoking, environmental pollutants, and GERD. Diagnosed using CT scans, pulmonary function tests, or biopsies, the condition has no cure. Treatments like antifibrotic drugs (pirfenidone, nintedanib), oxygen therapy, and pulmonary rehabilitation slow its progression. Early detection and a multidisciplinary healthcare approach are crucial for managing this debilitating disease effectively.